Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Jun;84(12):1664–1670. doi: 10.1054/bjoc.2001.1831

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissuenhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase

H M Collins 1, T M Morris 1, S A Watson 1
PMCID: PMC2363688  PMID: 11401321

Abstract

The matrix metalloproteinases, MMP-2 and MMP-9, are capable of degrading components of the basement membrane, a vital barrier breached during the progression of colorectal cancer. The regulation of MMP-2 activation and subsequent targets is vital to understanding the metastatic process. MMP-2 was not expressed by colorectal cancer cells (C170 and C170HM 2) in vitro but by stromal fibroblasts (46BR.1GI). There was induction of this MMP upon transwell co-cultivation of the colon cancer cells with the fibroblasts but in vivo growth did not lead to a similar increase in the metastatic tumour cells (C170HM 2), MMP-2 again being attributed to the stromal cells. MMP-2 mRNA was overexpressed in human colorectal tumours compared to normal colorectal tissue, which correlated with Dukes' stage and immunolocalized to the stromal compartment of the tumour tissue. The active form of the MMP-2 enzyme was also present in the colorectal tumour tissue (7/8) but essentially absent in all normal colon samples examined (1/8). MMP-2 activation was not related to an increase in MT-1-MMP mRNA or a decrease in the specific inhibitor TIMP-2 in human tissue. There was however an increase in MMP-2/TIMP-2 ratio in tumour compared to normal. MMP-9, a target of active MMP-2, was present in the metastatic cell line but expression was down-regulated in the tumour cells in vivo, gelatin analysis revealed that MMP-9 was almost entirely attributable to the murine host, confirmed by PCR. There was no increase in mRNA for MMP-9 or its specific inhibitor TIMP-1 in colorectal tumour tissue compared to normal, MMP-9 protein localized to the inflammatory infiltrate. Fibroblast cells may provide malignant epithelial cells with a ready source of enzyme which is crucial to the metastatic process. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: matrix metalloproteinases, stromal fibroblasts, cancer cell invasion metastasis, quantitative RT-PCR

Full Text

The Full Text of this article is available as a PDF (377.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birkedal-Hansen H., Moore W. G., Bodden M. K., Windsor L. J., Birkedal-Hansen B., DeCarlo A., Engler J. A. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993;4(2):197–250. doi: 10.1177/10454411930040020401. [DOI] [PubMed] [Google Scholar]
  2. Biswas C., Zhang Y., DeCastro R., Guo H., Nakamura T., Kataoka H., Nabeshima K. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res. 1995 Jan 15;55(2):434–439. [PubMed] [Google Scholar]
  3. Brown P. D., Levy A. T., Margulies I. M., Liotta L. A., Stetler-Stevenson W. G. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 1990 Oct 1;50(19):6184–6191. [PubMed] [Google Scholar]
  4. D'Errico A., Garbisa S., Liotta L. A., Castronovo V., Stetler-Stevenson W. G., Grigioni W. F. Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod Pathol. 1991 Mar;4(2):239–246. [PubMed] [Google Scholar]
  5. Davies B., Waxman J., Wasan H., Abel P., Williams G., Krausz T., Neal D., Thomas D., Hanby A., Balkwill F. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res. 1993 Nov 15;53(22):5365–5369. [PubMed] [Google Scholar]
  6. Durrant L. G., Robins R. A., Pimm M. V., Perkins A. C., Armitage N. C., Hardcastle J. D., Baldwin R. W. Antigenicity of newly established colorectal carcinoma cell lines. Br J Cancer. 1986 Jan;53(1):37–45. doi: 10.1038/bjc.1986.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ellerbroek S. M., Fishman D. A., Kearns A. S., Bafetti L. M., Stack M. S. Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin. Cancer Res. 1999 Apr 1;59(7):1635–1641. [PubMed] [Google Scholar]
  8. Fridman R., Toth M., Peña D., Mobashery S. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res. 1995 Jun 15;55(12):2548–2555. [PubMed] [Google Scholar]
  9. Harris E. D., Jr Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med. 1990 May 3;322(18):1277–1289. doi: 10.1056/NEJM199005033221805. [DOI] [PubMed] [Google Scholar]
  10. Heppner K. J., Matrisian L. M., Jensen R. A., Rodgers W. H. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol. 1996 Jul;149(1):273–282. [PMC free article] [PubMed] [Google Scholar]
  11. Hewitt R. E., Leach I. H., Powe D. G., Clark I. M., Cawston T. E., Turner D. R. Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int J Cancer. 1991 Nov 11;49(5):666–672. doi: 10.1002/ijc.2910490507. [DOI] [PubMed] [Google Scholar]
  12. Hyuga S., Nishikawa Y., Sakata K., Tanaka H., Yamagata S., Sugita K., Saga S., Matsuyama M., Shimizu S. Autocrine factor enhancing the secretion of M(r) 95,000 gelatinase (matrix metalloproteinase 9) in serum-free medium conditioned with murine metastatic colon carcinoma cells. Cancer Res. 1994 Jul 1;54(13):3611–3616. [PubMed] [Google Scholar]
  13. Lehti K., Lohi J., Valtanen H., Keski-Oja J. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem J. 1998 Sep 1;334(Pt 2):345–353. doi: 10.1042/bj3340345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lengyel E., Gum R., Juarez J., Clayman G., Seiki M., Sato H., Boyd D. Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. Cancer Res. 1995 Feb 15;55(4):963–967. [PubMed] [Google Scholar]
  15. Liabakk N. B., Talbot I., Smith R. A., Wilkinson K., Balkwill F. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res. 1996 Jan 1;56(1):190–196. [PubMed] [Google Scholar]
  16. Masuda H., Aoki H. Host expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in normal colon tissue affects metastatic potential of colorectal cancer. Dis Colon Rectum. 1999 Mar;42(3):393–397. doi: 10.1007/BF02236360. [DOI] [PubMed] [Google Scholar]
  17. Masure S., Nys G., Fiten P., Van Damme J., Opdenakker G. Mouse gelatinase B. cDNA cloning, regulation of expression and glycosylation in WEHI-3 macrophages and gene organisation. Eur J Biochem. 1993 Nov 15;218(1):129–141. doi: 10.1111/j.1432-1033.1993.tb18359.x. [DOI] [PubMed] [Google Scholar]
  18. Mc Donnell S., Chaudhry V., Mansilla-Soto J., Zeng Z. S., Shu W. P., Guillem J. G. Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo. Clin Exp Metastasis. 1999 Jun;17(4):341–349. doi: 10.1023/a:1006651019335. [DOI] [PubMed] [Google Scholar]
  19. Noël A. C., Polette M., Lewalle J. M., Munaut C., Emonard H. P., Birembaut P., Foidart J. M. Coordinate enhancement of gelatinase A mRNA and activity levels in human fibroblasts in response to breast-adenocarcinoma cells. Int J Cancer. 1994 Feb 1;56(3):331–336. doi: 10.1002/ijc.2910560306. [DOI] [PubMed] [Google Scholar]
  20. Ornstein D. L., MacNab J., Cohn K. H. Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancer. Clin Exp Metastasis. 1999 May;17(3):205–212. doi: 10.1023/a:1006562818088. [DOI] [PubMed] [Google Scholar]
  21. Page R. C. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res. 1991 May;26(3 Pt 2):230–242. doi: 10.1111/j.1600-0765.1991.tb01649.x. [DOI] [PubMed] [Google Scholar]
  22. Parsons S. L., Watson S. A., Collins H. M., Griffin N. R., Clarke P. A., Steele R. J. Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy. Br J Cancer. 1998 Dec;78(11):1495–1502. doi: 10.1038/bjc.1998.712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pender S. L., Tickle S. P., Docherty A. J., Howie D., Wathen N. C., MacDonald T. T. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol. 1997 Feb 15;158(4):1582–1590. [PubMed] [Google Scholar]
  24. Polette M., Gilles C., Marchand V., Seiki M., Tournier J. M., Birembaut P. Induction of membrane-type matrix metalloproteinase 1 (MT1-MMP) expression in human fibroblasts by breast adenocarcinoma cells. Clin Exp Metastasis. 1997 Mar;15(2):157–163. doi: 10.1023/a:1018404927753. [DOI] [PubMed] [Google Scholar]
  25. Poulsom R., Pignatelli M., Stetler-Stevenson W. G., Liotta L. A., Wright P. A., Jeffery R. E., Longcroft J. M., Rogers L., Stamp G. W. Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol. 1992 Aug;141(2):389–396. [PMC free article] [PubMed] [Google Scholar]
  26. Pyke C., Ralfkiaer E., Tryggvason K., Danø K. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol. 1993 Feb;142(2):359–365. [PMC free article] [PubMed] [Google Scholar]
  27. Saito K., Takeha S., Shiba K., Matsuno S., Sorsa T., Nagura H., Ohtani H. Clinicopathologic significance of urokinase receptor- and MMP-9-positive stromal cells in human colorectal cancer: functional multiplicity of matrix degradation on hematogenous metastasis. Int J Cancer. 2000 Apr 1;86(1):24–29. doi: 10.1002/(sici)1097-0215(20000401)86:1<24::aid-ijc4>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  28. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 1994 Jul 7;370(6484):61–65. doi: 10.1038/370061a0. [DOI] [PubMed] [Google Scholar]
  29. Segain J. P., Harb J., Grégoire M., Meflah K., Menanteau J. Induction of fibroblast gelatinase B expression by direct contact with cell lines derived from primary tumor but not from metastases. Cancer Res. 1996 Dec 1;56(23):5506–5512. [PubMed] [Google Scholar]
  30. Shimizu S., Nishikawa Y., Kuroda K., Takagi S., Kozaki K., Hyuga S., Saga S., Matsuyama M. Involvement of transforming growth factor beta1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells. Cancer Res. 1996 Jul 15;56(14):3366–3370. [PubMed] [Google Scholar]
  31. Stanton H., Gavrilovic J., Atkinson S. J., d'Ortho M. P., Yamada K. M., Zardi L., Murphy G. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. J Cell Sci. 1998 Sep;111(Pt 18):2789–2798. doi: 10.1242/jcs.111.18.2789. [DOI] [PubMed] [Google Scholar]
  32. Stetler-Stevenson W. G., Liotta L. A., Kleiner D. E., Jr Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 1993 Dec;7(15):1434–1441. doi: 10.1096/fasebj.7.15.8262328. [DOI] [PubMed] [Google Scholar]
  33. Watson S. A., Morris T. M., Crosbee D. M., Hardcastle J. D. A hepatic invasive human colorectal xenograft model. Eur J Cancer. 1993;29A(12):1740–1745. doi: 10.1016/0959-8049(93)90117-x. [DOI] [PubMed] [Google Scholar]
  34. Wells G. M., Catlin G., Cossins J. A., Mangan M., Ward G. A., Miller K. M., Clements J. M. Quantitation of matrix metalloproteinases in cultured rat astrocytes using the polymerase chain reaction with a multi-competitor cDNA standard. Glia. 1996 Dec;18(4):332–340. [PubMed] [Google Scholar]
  35. Westermarck J., Kähäri V. M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999 May;13(8):781–792. [PubMed] [Google Scholar]
  36. Zeng Z. S., Guillem J. G. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases. Br J Cancer. 1995 Sep;72(3):575–582. doi: 10.1038/bjc.1995.376. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES